Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018603 · ClinicalTrials.gov registry record · Phase 1
Guanfacine for the Treatment of Post Traumatic Stress Disorder (PTSD)
A Phase 1 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00018603 is a Phase 1 study that has completed, run by US Department of Veterans Affairs.
The verdict
NCT00018603, a Phase 1 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
This is a double-blind, placebo-controlled, randomized study lasting 8 weeks. Purpose of the study is two-fold: first, to use a pharmacological agent to treat symptoms of PTSD, and second, to explore neurobiological mechanisms of action of guanfacine.
Interventions
- DRUG guanfacine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-11 |
| Est. Completion | 2002-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00018603
The ClinicalTrials.gov registry entry for NCT00018603 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which guanfacine is the first listed.
NCT00018603 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00018603 about?
NCT00018603 is a clinical study titled "Guanfacine for the Treatment of Post Traumatic Stress Disorder (PTSD)". This is a double-blind, placebo-controlled, randomized study lasting 8 weeks. Purpose of the study is two-fold: first, to use a pharmacological agent to treat symptoms of PTSD, and second, to explore neurobiological mechanisms of action of guanfacine.
What is the current status of trial NCT00018603?
This trial is currently completed. It is a Phase 1 study. The study started on 1999-11. Estimated completion is 2002-10.
What interventions are being tested in trial NCT00018603?
The interventions under investigation include: guanfacine (DRUG).
Who is sponsoring clinical trial NCT00018603?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.